Price
Target price
€28.60
€28.60
1.420%
0.4
1.420%
€24.77
19.07.24 / Stuttgart Stock Exchange
WKN: 897013 / Symbol: IART / Name: Integra / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Integra LifeSciences Holdings Corp Stock
Integra LifeSciences Holdings Corp gained 1.420% today.
Based on 3 Buy predictions and 4 Sell predictions the sentiment towards Integra LifeSciences Holdings Corp is rather balanced.
A slightly negative potential of -16.08% at a current price of 28.6 € for Integra LifeSciences Holdings Corp is the result of a target price of 24 €.
Pros and Cons of Integra LifeSciences Holdings Corp in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Integra LifeSciences Holdings Corp vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Integra LifeSciences Holdings Corp | 1.420% | 5.147% | 3.623% | -29.557% | -27.411% | -50.261% | -41.405% |
Neogen Corp. | -1.860% | 2.649% | 0.000% | - | - | - | - |
Bio-Rad Labs Inc. A | -2.200% | -1.254% | 2.340% | -25.981% | -6.165% | -51.239% | - |
Merit Medical Systems | -1.280% | -3.145% | 2.667% | 4.762% | 13.235% | 49.515% | 56.663% |
Comments
Integra LifeSciences Holdings Co. (NASDAQ: IART) had its price target raised by analysts at Morgan Stanley from $24.00 to $27.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) had its price target lowered by analysts at Morgan Stanley from $37.00 to $24.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) had its price target lowered by analysts at Bank of America Co. from $42.00 to $26.00. They now have an "underperform" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat